These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1860243)

  • 1. Therapeutic fibrinolysis. What should follow?
    Stead NW
    Circulation; 1991 Aug; 84(2):948-50. PubMed ID: 1860243
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.
    Haskel EJ; Torr SR; Day KC; Palmier MO; Wun TC; Sobel BE; Abendschein DR
    Circulation; 1991 Aug; 84(2):821-7. PubMed ID: 1860224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are low-molecular-weight heparins useful for the prophylaxis and treatment of arterial thrombi?
    Samama CM; Combe S; Ill P; Barre E; Dreux S; Viars P
    Haemostasis; 1996; 26 Suppl 2():57-64. PubMed ID: 8707168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular function tests for diagnosis of blood coagulation disorders].
    Maruyama I
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):839-43. PubMed ID: 1919197
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and medical treatment of polyregional vascular lesions].
    Di Perri T
    Cardiologia; 1985 Nov; 30(11):1021-3. PubMed ID: 3834978
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.
    Day KC; Hoffman LC; Palmier MO; Kretzmer KK; Huang MD; Pyla EY; Spokas E; Broze GJ; Warren TG; Wun TC
    Blood; 1990 Oct; 76(8):1538-45. PubMed ID: 2207329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombosis and antithrombotic therapy in the elderly].
    Páramo JA; Varea S; Lecumberri R
    Med Clin (Barc); 2011 Oct; 137(10):468-71. PubMed ID: 21752408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of retinal vascular accidents].
    Girard P; Morlot C; Houtteville P; Forest A
    Rev Med Interne; 1980; 1(2):259-63. PubMed ID: 7256018
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.
    Kumar A; Villani MP; Patel UK; Keith JC; Schaub RG
    Circulation; 1999 Mar; 99(10):1363-9. PubMed ID: 10077522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The present status of fibrinolytic therapy].
    Koller F
    Bull Schweiz Akad Med Wiss; 1973 Nov; 29(4):263-75. PubMed ID: 4771353
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing the scope of preventative and therapeutic approaches in atherothrombosis.
    Peter K; Lip GY
    Thromb Haemost; 2010 Mar; 103(3):487-8. PubMed ID: 20135057
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy.
    Sajadi S; Ezekowitz MD; Dhond A; Netrebko P
    Drug News Perspect; 2003; 16(6):363-9. PubMed ID: 12973447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protracted use of dicoumarol anticoagulants in the treatment of peripheral arteriopathies.
    Raso AM; Roviera C; Scevola G
    Panminerva Med; 1975; 16(7-8):238-45. PubMed ID: 45868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medical therapy of acute peripheral ischemia].
    Basellini A; Martelli E; Losa S
    Minerva Med; 1985 Mar; 76(11):501-3. PubMed ID: 3982684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antithrombotic drugs in peripheral arterial diseases].
    Verhaeghe R
    J Mal Vasc; 1983; 8(1):23-7. PubMed ID: 6221056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents].
    Kalishevskaia TM; Golubeva MG; Bashkov GV
    Patol Fiziol Eksp Ter; 1988; (3):24-8. PubMed ID: 2902551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Should one employ anticoagulants or platelet inhibitors in the long-term prophylaxis, with or without surgery, of arterial occlusive disease?].
    Breddin J; Hess H
    Med Welt; 1981 Sep; 32(37):1343-4. PubMed ID: 6795422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G; Tallarida G; Baldoni F; Raimondi G; Grimaldi I; Sangiorgi M
    Clin Ter; 1985 Jul; 114(1):3-26. PubMed ID: 2864161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.